All > Prevention > Vitamin D

Bolus vitamin D3 for Coronavirus

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Coronavirus+8 MoreBolus vitamin D3 - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether vitamin D supplementation can help reduce the severity of COVID-19 symptoms and the body's inflammatory response to the virus.

Eligible Conditions
  • Coronavirus
  • Vitamin D Deficiency
  • Viral Respiratory Infection

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
Mitoquinone/mitoquinol mesylate
1
AV-001 Injection with standard of care (SOC).
2
Ddrops® products, 50,000 IU, Oral

Study Objectives

3 Primary · 10 Secondary · Reporting Duration: baseline, 2 and 4 weeks, then months 3, 6, 9 and 12 in COVID-19 positive participants

Month 12
Signs and symptoms of rhino/sinusitis
Month 12
Paffenberger Physical Activity Assessment
Month 12
Change in inflammatory cytokine concentration (10 cytokine panel Elisa: Interferon (INF)-gamma, Interleukin (IL)-1beta, IL-2, IL-3, IL-4, IL-6, IL-8, IL-10, IL-13, Tumor Necrosis Factor (TNF)-alpha
Month 12
Charlson Comorbidity survey
NCI Dietary Intake
baseline visit
NEO-Personality Inventory
Month 3
Change in total circulating 25(OH)D concentration in COVID-19 positives
Month 12
GrassrootsHealth Monthly Health assessment
daily for 2 weeks
Respiratory symptoms
Month 12
Change in SARS-CoV-2 antibody titers
monthly for 1 year
Pandemic stress
Perceived stress
Year 1
Change in total circulating 25(OH)D concentration

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
Mitoquinone/mitoquinol mesylate
2
AV-001 Injection with standard of care (SOC).
3
Ddrops® products, 50,000 IU, Oral

Trial Design

4 Treatment Groups

COVID-19 Negative Active Treatment
1 of 4
COVID-19 Positive Active Treatment
1 of 4
COVID-19 Negative Placebo
1 of 4
COVID-19 Positive Placebo
1 of 4

Experimental Treatment

Non-Treatment Group

140 Total Participants · 4 Treatment Groups

Primary Treatment: Bolus vitamin D3 · Has Placebo Group · Phase 4

COVID-19 Negative Active Treatment
Drug
Experimental Group · 1 Intervention: Daily Vitamin D3 · Intervention Types: Drug
COVID-19 Positive Active TreatmentExperimental Group · 2 Interventions: Bolus vitamin D3, Daily Vitamin D3 · Intervention Types: Drug, Drug
COVID-19 Negative Placebo
Drug
PlaceboComparator Group · 1 Intervention: Daily placebo · Intervention Types: Drug
COVID-19 Positive PlaceboPlaceboComparator Group · 2 Interventions: Bolus placebo, Daily placebo · Intervention Types: Drug, Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 2 and 4 weeks, then months 3, 6, 9 and 12 in covid-19 positive participants

Who is running the clinical trial?

Grassroots Health Nutrition InstituteUNKNOWN
Medical University of South CarolinaLead Sponsor
837 Previous Clinical Trials
5,378,450 Total Patients Enrolled
ZRT LaboratoryOTHER
1 Previous Clinical Trials
220 Total Patients Enrolled
Carol L Wagner, MDPrincipal InvestigatorMedical University of South Carolina
2 Previous Clinical Trials
906 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top